동물 모델 시장 규모, 점유율, 성장 분석 : 동물 종류별, 기술별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Animal Model Market size was valued at USD 3.03 Billion in 2024 and is poised to grow from USD 3.28 Billion in 2025 to USD 6.11 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The global animal model market serves as a vital resource for researchers, offering models that accurately replicate human physiology and pathology. Key drivers for market expansion include the rising incidence of chronic diseases such as cancer, cardiovascular issues, and neurological disorders. Notably, advancements in genetically modified animals, like transgenic mice, are enabling in-depth exploration of specific genes and their association with disease progression. Furthermore, the growing emphasis on personalized medicine creates demand for patient-derived animal models that enhance tailored therapeutic approaches. Despite challenges like ethical dilemmas and emerging alternatives, the animal model market remains instrumental in disease understanding and drug innovation. Continuous advancements in model development further underscore opportunities for growth within this dynamic sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Model market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Animal Model Market Segments Analysis

Global Animal Model Market is segmented by Animal Type, Technology, Application, End User and region. Based on Animal Type, the market is segmented into Mice, Rat, Guinea Pigs, Rabbits, Hamsters and Others. Based on Technology, the market is segmented into CRISPR, Microinjection and Embryonic Stem Cell Injection. Based on Application, the market is segmented into Research and Development, Production and Quality Control. Based on End User, the market is segmented into Research Institutes, Educational Institutes, Pharmaceutical Companies and Contract Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Animal Model Market

The global animal model market is significantly driven by advancements in genomics and precision medicine, highlighting the necessity for animal models that closely reflect individual patient characteristics and their responses to various treatments. Researchers and pharmaceutical companies are increasingly relying on these models to investigate specific genetic variations and to create targeted therapeutic approaches. The emergence of patient-derived xenograft (PDX) models, which involve implanting patient tumor samples into animals for drug testing, has become a prominent avenue in this field. These models enable the evaluation of treatment efficacy tailored to individual patients, thereby propelling the demand for animal models in the realm of personalized medicine.

Restraints in the Global Animal Model Market

Despite notable progress in the field of animal models, ethical concerns and animal welfare issues continue to pose significant challenges. The employment of animals in research raises critical ethical questions and ignites discussions surrounding their humane treatment. Increasing public scrutiny, coupled with stringent animal welfare regulations, has intensified the examination of animal model usage, particularly in regions with robust welfare legislation. These ethical considerations and regulatory frameworks hinder the growth of the animal model market and spur the urgent need for alternative technologies and models that can replace traditional practices while maintaining scientific integrity.

Market Trends of the Global Animal Model Market

The Global Animal Model market is witnessing a notable trend toward humanized and translational models, driven by the demand for greater relevance to human physiology and disease mechanisms. Researchers are increasingly focusing on creating animal models that incorporate human cells, tissues, and genetic modifications to enhance their accuracy in mimicking human conditions. This shift is particularly evident in the development of humanized mice, which allows for more effective studies of immune-related diseases and the testing of advanced immunotherapies. As this trend continues, it reflects the broader goal of improving the predictability and applicability of animal models in drug development and disease research, ultimately leading to more effective therapeutic solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Animal Model Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Mice
• Rat
• Guinea Pigs
• Rabbits
• Hamsters
• Others

Global Animal Model Market Size by Technology & CAGR (2026-2033)

• Market Overview
• CRISPR
• Microinjection
• Embryonic Stem Cell Injection

Global Animal Model Market Size by Application & CAGR (2026-2033)

• Market Overview
• Research and Development
• Production
• Quality Control

Global Animal Model Market Size by End User & CAGR (2026-2033)

• Market Overview
• Research Institutes
• Educational Institutes
• Pharmaceutical Companies
• Contract Research Organizations

Global Animal Model Market Size & CAGR (2026-2033)

• North America (Animal Type, Technology, Application, End User)
  • US
  • Canada
• Europe (Animal Type, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Animal Type, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Animal Type, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Animal Type, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Jackson Laboratory (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Janvier Labs (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genoway (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ozgene (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hera Biolabs (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crown Bioscience (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inotiv (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Transgenic (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JSR Life Sciences (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocytogen (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Harbour BioMed (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyagen Biosciences (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Discovery (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellectis (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CRISPR Therapeutics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Editas Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intellia Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations